DrugPatentWatch Database Preview
Pharmadax Inc Company Profile
» See Plans and Pricing
What is the competitive landscape for PHARMADAX INC, and what generic and branded alternatives to PHARMADAX INC drugs are available?
PHARMADAX INC has five approved drugs.
Summary for Pharmadax Inc
| US Patents: | 0 |
| Tradenames: | 4 |
| Ingredients: | 4 |
| NDAs: | 5 |
Drugs and US Patents for Pharmadax Inc
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Pharmadax Inc | METOPROLOL SUCCINATE | metoprolol succinate | TABLET, EXTENDED RELEASE;ORAL | 203028-002 | Mar 31, 2020 | AB | RX | No | No | Start Trial | Start Trial | ||||
| Pharmadax Inc | ENTECAVIR | entecavir | TABLET;ORAL | 212106-001 | Aug 10, 2020 | AB | RX | No | No | Start Trial | Start Trial | ||||
| Pharmadax Inc | QUETIAPINE FUMARATE | quetiapine fumarate | TABLET, EXTENDED RELEASE;ORAL | 206260-005 | May 9, 2017 | AB | RX | No | No | Start Trial | Start Trial | ||||
| Pharmadax Inc | QUETIAPINE FUMARATE | quetiapine fumarate | TABLET, EXTENDED RELEASE;ORAL | 206260-004 | May 9, 2017 | AB | RX | No | No | Start Trial | Start Trial | ||||
| Pharmadax Inc | LEVETIRACETAM | levetiracetam | TABLET, EXTENDED RELEASE;ORAL | 201464-001 | May 25, 2012 | AB | RX | No | No | Start Trial | Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
